 Beta-Lactam-beta-lactamase-inhibitor combinations active experimental endocarditis beta-lactamase-producing oxacillin-resistant staphylococci Optimal therapeutic strategies serious infections borderline oxacillin-resistant Staphylococcus aureus BORSA ORSA strains Recent evidence dominant penicillin-binding protein ORSA strains PBP good affinity ampicillin strains beta-lactamase vivo efficacy combination ampicillin sulbactam vancomycin ORSA strains moderate resistance BORSA attributable hyperproduction beta-lactamase vivo efficacy ampicillin sulbactam organisms Experimental aortic endocarditis rabbits following strains beta-lactamase-producing BORSA strain beta-lactamase-producing ORSA strain beta-lactamase-negative clone animals BORSA endocarditis ampicillin sulbactam oxacillin effective mean intravegetation bacterial densities ampicillin therapy animals endocarditis beta-lactamase-producing ORSA strain ampicillin sulbactam mean vegetation bacterial densities regimens endocarditis beta-lactamase-negative ORSA clone ampicillin vancomycin mean intravegetation bacterial densities data infections beta-lactamase-producing BORSA manner similar infections oxacillin-susceptible strains oxacillin ampicillin sulbactam efficacious